Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

CRC × Irinotecan × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 406 Rectal Neoplasms 152 Colonic Neoplasms 150 Pancreatic Neoplasms 112 Stomach Neoplasms 110 Neoplasm Metastasis 69 Esophageal Neoplasms 60 Esophageal Squamous Cell Carcinoma 32 Neoplasms 31 Adenocarcinoma Of Esophagus 27 Gastrointestinal Neoplasms 17 Cholangiocarcinoma 13 Gallbladder Neoplasms 12 Carcinoma, Hepatocellular 12 Biliary Tract Neoplasms 12 Adenocarcinoma 12 Colorectal Cancer Metastatic 11 Carcinoma, Non-Small-Cell Lung 11 Breast Neoplasms 11 Liver Neoplasms 10 Digestive System Neoplasms 10 Ovarian Neoplasms 9 Small Cell Lung Carcinoma 8 Locally Advanced Rectal Cancer 8 Intestinal Neoplasms 8 Bile Duct Neoplasms 8 Carcinoma 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Digestive System Diseases 6 Appendiceal Neoplasms 6

Interventions

spartalizumab 1 Radiosurgery 1 Oncolytic Virotherapy 1 Leucovorin 1 Irinotecan 1 IFL protocol 1 Fluorouracil 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07381309 2026-02-02

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡